Dan Seff is listed as a director on 11 SEC Form D filings by 2 issuers between Jul 2009 and Sep 2024: STAQ Pharma, Inc. (Denver, CO — pharmaceuticals — 2019–2024; $30.3M reported sold to 23 investors) and Sharklet Technologies, Inc. (Aurora, CO — biotechnology — 2009–2012; $2M reported sold to 17 investors).
What this means 2 separate companies raised money with this person listed as director, over about 15 years. Across those companies the filings report $32.3M sold in total.
Listed alongside Joseph W Bagan (11 shared filings), Mark M Spiecker (11 shared filings), Jeffrey L Hval (9 shared filings), Chet Kaczor (8 shared filings), JERROD MILTON (8 shared filings) and 13 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Dan. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 5 court cases matching the name, 4 bankruptcy cases matching the name listed in Key records below.
What this means 9 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 11 public filings for Dan Seff and found 6 differences: Offering amount changed between filings; 5 offerings have no amendment in the last 12 months and may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.